DiaMedica Share Price

DiaMedica Share Price

NASDAQ: DMAC | Small Cap | Healthcare
$8.51
+$0.13 (1.49%) Last updated on 19 Nov, 2026 | 01:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

DiaMedica Stock Performance

Open
$8.81
Prev. Close
$8.38
Circuit Range
N/A
Day Range
$8.58 - $8.81
Year Range
$5.28 - $10.94
Volume
3,435
Average Traded
$8.64

DiaMedica Share Price Today

As of 19 November 2026, DiaMedica Therapeutics Inc.'s share price is $8.51. The stock opened at $8.81, compared to its previous close of $8.38. During today's trading session, DiaMedica Therapeutics Inc.'s share price traded between $8.58 and $8.81, with an average price of $8.70. Over the past 52 weeks, the stock has recorded a high of $10.94 and a low of $5.28. In terms of performance, DiaMedica Therapeutics Inc.'s share price has risen by 41.75% over the last six months and is down 1.33% on a year-on-year basis.

DiaMedica Share Price Chart

Line chart of the DiaMedica price trend over the selected period. The price rose overall, ranging from 8.48 to 8.81, ending at 8.51.
$8.58$8.81
L
Show Current Price
H

DiaMedica Stock Fundamentals & Key Indicators

Market Cap
$399.57M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.70
Revenue (TTM)
$0.00
Return On Equity (TTM)
-97.88%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-17.75%

DiaMedica Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.62-$8.71-$10.04-$10.15
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-1.04%-15.27%-1.10%

DiaMedica Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.68-$19.38-$24.43-$32.74
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-41.67%-26.06%-34.02%

DiaMedica Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.741.740.490.56
Current Assets60.6344.6153.6833.84
Total Assets61.3746.3554.1634.4
Non Current Liabilities0.130.240.320.4
Current Liabilities5.135.392.792.17
Total Liabilities5.265.633.12.57
Shareholders' Equity56.1140.7251.0631.83

DiaMedica Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-29.06-22.08-18.73-11.51
Investing-2.198.56-18.311.54
Financing43.8811.9936.84-0.01

About DiaMedica

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.

DiaMedica Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$9.33
$8.58
-7.19%
Oct 2026
$8.25
$9.24
+10.98%
Sep 2026
$6.31
$8.33
+23.59%
Aug 2026
$6.35
$6.74
+6.65%
Jul 2026
$7.14
$6.32
-10.61%
Jun 2026
$5.94
$7.07
+17.83%
May 2026
$5.93
$6.00
-0.50%
Apr 2026
$6.80
$6.03
-10.93%
Mar 2026
$7.82
$6.77
-14.74%
Feb 2026
$8.15
$7.94
-1.37%
Jan 2026
$7.81
$8.05
+1.00%
Dec 2025
$8.43
$7.97
-7.54%

DiaMedica Share Price FAQs